A citation-based method for searching scientific literature

Huiping Ding, Mei-Chuan Ko. Exp Neurol 2021
Times Cited: 5







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.
Huiping Ding, Norikazu Kiguchi, Dennis Yasuda, Pankaj R Daga, Willma E Polgar, James J Lu, Paul W Czoty, Shiroh Kishioka, Nurulain T Zaveri, Mei-Chuan Ko. Sci Transl Med 2018
80
80

A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
Huiping Ding, Paul W Czoty, Norikazu Kiguchi, Gerta Cami-Kobeci, Devki D Sukhtankar, Michael A Nader, Stephen M Husbands, Mei-Chuan Ko. Proc Natl Acad Sci U S A 2016
74
60


Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
H Ding, K Hayashida, T Suto, D D Sukhtankar, M Kimura, V Mendenhall, M C Ko. Br J Pharmacol 2015
44
60


BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
Norikazu Kiguchi, Huiping Ding, Gerta Cami-Kobeci, Devki D Sukhtankar, Paul W Czoty, Heather B DeLoid, Fang-Chi Hsu, Lawrence Toll, Stephen M Husbands, Mei-Chuan Ko. Br J Anaesth 2019
28
60

Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
Huiping Ding, Norikazu Kiguchi, David A Perrey, Thuy Nguyen, Paul W Czoty, Fang-Chi Hsu, Yanan Zhang, Mei-Chuan Ko. Br J Anaesth 2020
16
60


Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Klaus Linz, Thomas Christoph, Thomas M Tzschentke, Thomas Koch, Klaus Schiene, Michael Gautrois, Wolfgang Schröder, Babette Y Kögel, Horst Beier, Werner Englberger,[...]. J Pharmacol Exp Ther 2014
124
40


Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study.
Karin Göhler, Marta Sokolowska, Kerri A Schoedel, Robert Nemeth, Elke Kleideiter, Isabella Szeto, Marie-Henriette Eerdekens. J Clin Psychopharmacol 2019
23
40

Hot topics in opioid pharmacology: mixed and biased opioids.
Ammar A H Azzam, John McDonald, David G Lambert. Br J Anaesth 2019
69
40

Cancer-related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double-blind, noninferiority trial.
Marie-Henriette Eerdekens, Sofia Kapanadze, Erika Dietlind Koch, Georg Kralidis, Gisela Volkers, Sam Hjelmeland Ahmedzai, Winfried Meissner. Eur J Pain 2019
23
40


The role of central mu opioid receptors in opioid-induced itch in primates.
M C H Ko, M S Song, T Edwards, H Lee, N N Naughton. J Pharmacol Exp Ther 2004
97
40

Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
M C Ko, M D Johnson, E R Butelman, K J Willmont, H I Mosberg, J H Woods. J Pharmacol Exp Ther 1999
40
40


Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial.
Annette Christoph, Marie-Henriette Eerdekens, Maurits Kok, Gisela Volkers, Rainer Freynhagen. Pain 2017
59
40

Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors.
Thomas M Tzschentke, Klaus Linz, Thomas Koch, Thomas Christoph. Handb Exp Pharmacol 2019
21
40

Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Mei-Chuan Ko, James H Woods, William E Fantegrossi, Chad M Galuska, Jürgen Wichmann, Eric P Prinssen. Neuropsychopharmacology 2009
78
40

Animal research: reporting in vivo experiments: the ARRIVE guidelines.
Carol Kilkenny, William Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman. Br J Pharmacol 2010
40


Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, Julie Sanchez, Herman D Lim, Claudia Alamein, Preeti Manandhar, Marina Santiago, Sebastian Fritzwanker, Frank Schmiedel,[...]. Sci Signal 2020
126
40


A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.
Scott M DeWire, Dennis S Yamashita, David H Rominger, Guodong Liu, Conrad L Cowan, Thomas M Graczyk, Xiao-Tao Chen, Philip M Pitis, Dimitar Gotchev, Catherine Yuan,[...]. J Pharmacol Exp Ther 2013
401
40

Effects of NOP-Related Ligands in Nonhuman Primates.
Norikazu Kiguchi, Mei-Chuan Ko. Handb Exp Pharmacol 2019
13
40

Genomic responses in mouse models poorly mimic human inflammatory diseases.
Junhee Seok, H Shaw Warren, Alex G Cuenca, Michael N Mindrinos, Henry V Baker, Weihong Xu, Daniel R Richards, Grace P McDonald-Smith, Hong Gao, Laura Hennessy,[...]. Proc Natl Acad Sci U S A 2013
40

Central N/OFQ-NOP Receptor System in Pain Modulation.
Norikazu Kiguchi, Huiping Ding, Mei-Chuan Ko. Adv Pharmacol 2016
41
40

Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates.
Huiping Ding, Claudio Trapella, Norikazu Kiguchi, Fang-Chi Hsu, Girolamo Caló, Mei-Chuan Ko. Anesthesiology 2021
6
40

Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey.
M C Holden Ko, Mary F Divin, Heeseung Lee, James H Woods, John R Traynor. J Pharmacol Exp Ther 2006
34
20


Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
Klaus Schiene, Wolfgang Schröder, Klaus Linz, Stefanie Frosch, Thomas M Tzschentke, Ulla Jansen, Thomas Christoph. Eur J Pharmacol 2018
16
20

Relative reinforcing effects of three opioids with different durations of action.
M C Ko, J Terner, S Hursh, J H Woods, G Winger. J Pharmacol Exp Ther 2002
79
20


Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.
Qianwei Shen, Yulin Deng, Roberto Ciccocioppo, Nazzareno Cannella. Front Psychiatry 2017
17
20


NOP agonist action of cebranopadol counteracts its liability to promote physical dependence.
Chiara Ruzza, Victor A Holanda, Elaine C Gavioli, Claudio Trapella, Girolamo Calo. Peptides 2019
8
20

Pathophysiology and management of opioid-induced pruritus.
Arjunan Ganesh, Lynne G Maxwell. Drugs 2007
61
20

A review of epidural and intrathecal opioids used in the management of postoperative pain.
Borja Mugabure Bujedo, Silvia González Santos, Amaia Uría Azpiazu. J Opioid Manag 2012
52
20



Why primate models matter.
Kimberley A Phillips, Karen L Bales, John P Capitanio, Alan Conley, Paul W Czoty, Bert A 't Hart, William D Hopkins, Shiu-Lok Hu, Lisa A Miller, Michael A Nader,[...]. Am J Primatol 2014
316
20

Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.
Kathleen T Brady, Jenna L McCauley, Sudie E Back. Am J Psychiatry 2016
167
20

Neuraxial morphine and respiratory depression: finding the right balance.
Pervez Sultan, Maria Cristina Gutierrez, Brendan Carvalho. Drugs 2011
74
20

Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
Kris Rutten, Wolfgang Schröder, Thomas Christoph, Thomas Koch, Thomas M Tzschentke. Eur J Pharmacol 2018
12
20

GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.
E R Butelman, M C Ko, J R Traynor, J A Vivian, M J Kreek, J H Woods. J Pharmacol Exp Ther 2001
35
20


Primer of postoperative pruritus for anesthesiologists.
Beverly Waxler, Zerin P Dadabhoy, Ljuba Stojiljkovic, Sara F Rabito. Anesthesiology 2005
37
20

Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.
Devki D Sukhtankar, Heeseung Lee, Kenner C Rice, Mei-Chuan Ko. Psychopharmacology (Berl) 2014
28
20

Principles of drug abuse liability assessment in laboratory animals.
Nancy A Ator, Roland R Griffiths. Drug Alcohol Depend 2003
182
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.